Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure: post hoc analysis of a randomised clinical trial

ERJ Open Res. 2021 Oct 4;7(4):00418-2021. doi: 10.1183/23120541.00418-2021. eCollection 2021 Oct.


In #COVID19 patients, presence of moderate-to-severe dyspnoea is a marker of disease severity correlated to clinical outcomes https://bit.ly/3Bp2G1b.